We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Life sciences recruiting specialist Coulter Partners has helped to recruit John Baker as chief executive officer and Jason Brown as chief business officer of biotechnology company IMU Biosciences. Founder and past CEO Adam Laing will assume the roles of president and chief scientific officer. “I am incredibly proud of what the IMU team has achieved to date,” said
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Lloyd Diamond as the new CEO of Nitinotes Surgical in Caesarea, Israel. He succeeds Raz Bar-On, who will continue as general manager. “We are thrilled to welcome Lloyd to lead Nitinotes into its next chapter of innovation and growth,” said John Barr, chairman of the
Chief development officers are crucial to life sciences organizations as they drive strategic planning and oversee the development of new products and therapies, ensuring alignment with market needs. They foster collaboration across research, regulatory, and commercial teams to streamline innovation and accelerate time to market. Finding these executives has kept executive search firms busy. Life
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Matthew Sassone as the new CEO of Tristel plc, a manufacturer of infection prevention products. He will replace Paul Swinney, the company’s founder and CEO of 30 years, who announced his plans to retire during 2023. Mr. Swinney will remain with the company for a suitable
Coulter Partners announces the strengthening of its management team with the promotion of Penny Sadler as Managing Partner. Penny Sadler brings 30 years of global search experience to her new role, with a specialization in medtech, diagnostics, and life sciences tools. She also possesses deep expertise in Benelux pharmaceuticals, as well as biotech startups and
Coulter Partners successfully completed a search assignment for ExpressionEdits and is pleased to announce the placement of Dr. Amrik Basran as Chief Scientific Officer (CSO). ExpressionEdits is a biotechnology company leveraging AI-driven insights and proprietary intronization technology to enhance protein expression. Dr. Basran is a seasoned drug discovery leader with over 20 years of experience,
Coulter Partners successfully completed a search assignment for Sensome and is pleased to announce the placement of Dr. Brian Burg, as Chief Innovation Officer. Sensome pioneers microsensing technology for instant intraoperative tissue analysis. Its revolutionary sensor technology transforms invasive medical devices into connected healthcare devices, combining the world’s smallest impedance-based microsensor with machine learning to
Coulter Partners successfully completed a search assignment for Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (“Bausch Health”) and is pleased to announce the placement of Jonathan Sadeh M.D., M.Sc., as Executive Vice President, Chief Medical Officer and Head of R&D. Bausch Health is a global company that develops, manufactures and markets a range of products primarily in
Coulter Partners successfully completed a search assignment for Our Future Health and is pleased to announce the placement of Andrew Miles, as Chief Business Officer (CBO). Our Future Health is an ambitious collaboration between the public, charity and private sectors to build the UK’s largest ever health research program – bringing people together to develop
News
Top hires for VC & PE portfolio companies Q1-2025
Evolution Italy: Life Science leaders gather for insightful discussions
Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign
BioInnovation Institute Breakfast Seminar Health Tech Ecosystem – Copenhagen
BIA Gala Dinner 2025
Top hires for VC & PE portfolio companies Q4-2024
Top global hires for large-cap, mid-cap and public companies H2-2024
Coulter Partners attends AESC Global Conference: Inspire. Innovate. Impact.
Coulter Partners hosts inaugural annual partners meeting
Top hires for VC & PE portfolio companies Q3-2024
Packed house for Coulter Partners’ latest HealthTech Ecosystem breakfast
Coulter Partners runs Vitality 10K to raise money for Kith & Kids charity
Top hires for VC & PE portfolio companies Q2-2024
Top global hires for large-cap, mid-cap and public companies H1-2024
D, E & I: VIEWS FROM LEADERSHIP SERIES – Ankit Mahadevia, MD, Founder and Chair of Spero Therapeutics, and author of Quiet Leader, Loud Results
Top hires for VC & PE portfolio companies Q1-2024
D, E & I: VIEWS FROM LEADERSHIP SERIES – Lene Gerlach, Founder and Chair of Women in Life Science Denmark (WiLD), and Partner at Eir Ventures
D, E & I: VIEWS FROM LEADERSHIP SERIES – Yael Gruenbaum-Cohen, Partner at aMoon and Founder of WE@HealthTech
Top hires for VC & PE portfolio companies Q4-2023
Top global hires for large-cap, mid-cap and public companies H2-2023
Top hires for VC & PE portfolio companies Q3-2023
Top hires for VC & PE portfolio companies Q2-2023
Top global hires for large-cap, mid-cap and public companies H1-2023
Top hires for VC & PE portfolio companies Q1-2023
D, E & I: Views From Leadership Series – Charlotte Valeur, Founder of Institute Of Neurodiversity, ION
Top hires for VC & PE portfolio companies Q4-2022
Top global hires for large-cap, mid-cap and public companies H2-2022
Diversity, Equity, & Inclusion: Views From Leadership Series- Quita Highsmith, Vice President and Chief Diversity Officer at Genentech
Diversity, Equity & Inclusion: Views from Leadership-Tomoko Adachi
Diversity, Equity & Inclusion: Views from Leadership-Corinne Le Goff